What does this research mean for the field?

Extending transcutaneous tibial nerve stimulation (TTNS) to 24 weeks improves symptoms in pediatric patients with overactive bladder and results in a significant number of late responders. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The objective is to assess the effects of extended transcutaneous tibial nerve stimulation (TTNS) on symptoms of pediatric overactive bladder.

March 7, 2026Open Access

Extended-course transcutaneous tibial nerve stimulation for pediatric overactive bladder: a 6-Month prospective single-arm study

Key Points

The objective is to assess the effects of extended transcutaneous tibial nerve stimulation (TTNS) on symptoms of pediatric overactive bladder.
Conducted a 6-month prospective single-arm study.
Administered TTNS to participants for 24 weeks.
Observed symptom improvements and response rates over the study period.
Extended TTNS significantly improved symptoms over 6 months.
A substantial number of late responders emerged from the treatment.
No loss of efficacy was observed compared to initial treatments.

Abstract

Extending TTNS to 24 weeks was associated with additional symptom improvement and a substantial proportion of late responders without loss of response. Findings suggest that continuing TTNS beyond 12 weeks may be considered for early nonresponders, pending confirmation in randomized, sham-controlled trials.

Bookmark

View Full Paper

Cite This Study

Cheng et al. (Wed,) studied this question.

synapsesocial.com/papers/69abc0de5af8044f7a4e977d https://doi.org/https://doi.org/10.1007/s00345-026-06249-9

Bookmark

View Full Paper